跳至主要内容
临床试验/NL-OMON49412
NL-OMON49412已完成不适用

A population PK study into teicoplanin in intensive care and haematology patients * a strategy towards model informed precision dosing (PLATO) - PLATO

Radboud Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. The patient is admitted to the ICU of the haematology department
  • 2. The patient is at least 18 years of age on the day of inclusion
  • 3. Is treated with teicoplanin as a part of standard care
  • 4. Is able and willing to sign the Informed Consent form

排除标准

  • 1. Has previously participated in this study
  • 2. Patient receives any form of RRT other than continuous venovenous
  • hemofiltration (CVVH).

研究者

相似试验